arrow
Back
S

Stéphane Champiat

The University of Texas MD Anderson Cancer Center

47H-index
478Paper Count
1.6WCitation Count
Published Papers 124
Publication Date
Outcomes of early-onset vs average-onset colorectal cancer patients on phase I matched and non-matched therapies
err2026-08-22
err0
errOAAI
errDaniel A. Fox; Deepak Bhamidipati; Heather Y. Lin; Louis E. Hinkle; Caitlynn Truc-Anh Pham; Jordi R. Ahnert; Stephane Champiat; Ecaterina E. Dumbrava; Siqing Fu; Lei Kang; Hung Le; Funda Meric-Bernstam; Aung Naing; Sarina A. Piha-Paul; Paula R. Pohlmann; Tin-Yun Tang; Apostolia M. Tsimberidou; Timothy A. Yap; Ryan W. Huey; David S. Hong
errShare
errSave
Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors
err2026-07-30
err0
errOAAI
errJU Jeong Uk Lim; DT Derrick Tao; PN Paul Nevins Selvadurai; EE Ecaterina Elena Dumbrava; AN Aung Naing; SC Stephane Champiat; OM Oriol Mirallas; LK Lei Kang; HL Hung Le; AM Apostolia Maria Tsimberidou; JR Jordi Rodon Ahnert; SA Sarina A. Piha-Paul; SF Siqing Fu; TA Timothy A. Yap; TT Tin-Yun Tang; FM Funda Meric-Bernstam; AS Ajay Sheshadri †; DS David S. Hong †
errShare
errSave
Future approaches to immune base biomarkers
err2026-06-06
err0
PREAI
errMatthieu Roulleaux Dugage; François-Xavier Danlos; Julien Vibert; Charles Pottier; Marie Naigeon; Anna Patrikidou; Ronan Flippot; Stéphane Champiat; Antoine Italiano; Aurélien Marabelle; Yohann Loriot
errShare
errSave
Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls
err2026-04-29
err0
errOAAI
errO. Mirallas; G. Pretelli; M. Balsa; P. Jiménez-Labaig; A. Hernando-Calvo; H. Nathan Tan; P. Selvadurai; P. Tallón de Lara; M. Vieito; J. Martin-Liberal; K.J. Harrington; S. Champiat; E. Garralda
errShare
errSave
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical Trials
err2026-04-02
err0
PREAI
errJ-D Fumet; M.Roulleaux Dugage; F-X Danlos; T. Hueso; D.J. Pinato; J. Luke; I. Melero Bermejo; P. Lorusso; J. Brody; K. Harrington; N.H. Segal; A. Diab; E. Gerralda Cabanas; T. Marron; R. Houot; S. Champiat; A. Marabelle
errShare
errSave
Telemedicine as a Gateway to Early-Phase Oncology Trials: Lessons from 14,000 Patients and Future Directions for Global Access and Equity
err2026-03-13
err0
errOAAI
errCarlos Torrado, MD; Clark R Andersen, MS; Lei Kang; Amanda L Brink; Taiwo Adesoye, MD, MDH; Hung Le; Clover J Patterson, APRN; Anna Poullard, APRN; Jessica A Osburn, APRN; Harold N Tan, MD; Mohamed A Gouda, MD; Sheena Charles, APRN; Gabriele E Urschel, APRN; Tin-Yun Tang, MD, PhD; David S Hong, MD; Stephane Champiat, MD; Aung Naing, MD; Apostolia M Tsimberidou, MD, PhD; Ecaterina E Dumbrava, MD; Sarina A Piha-Paul, MD; Jordi Rodon, MD, PhD; Timothy A Yap, MBBS, PhD; Paula R Pohlmann, MD, PhD; Funda Meric-Bernstam, MD, PhD; Siqing Fu, MD, PhD
errShare
errSave
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson
err2026-01-13
err0
errOAAI
errJeong Uk Lim; Heather Y. Lin; Lei Kang; Hung Le; Tin-Yun Tang; Stephane Champiat; Ecaterina Elena Dumbrava; Xiuning Le; Aung Naing; Sarina A. Piha-Paul; Jordi Rodon Ahnert; Apostolia Maria Tsimberidou; Timothy A. Yap; Siqing Fu; Funda Meric-Bernstam; David S. Hong
errShare
errSave
Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer Immunotherapy
err2025-12-11
err0
PREAI
errCarolina Colli Cruz; Maria Julia Moura Nascimento Santos; Sharada Wali; Cristina Natha; Rachel Mortan; Rohan Ahuja; Jarrett Rong; Tanvi Gupta; Irene Jeong-Ah Lee; Varun Vemulapalli; Sean Ngo; Kei Takigawa; Krishnavathana Varatharajalu; Karen C. Kim; Kathryn Bollin; Stephane Champiat; Mehnaz A. Shafi; Anusha S. Thomas; Yinghong Wang
errShare
errSave
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS
err2025-12-06
err0
PREAI
errBingnan Zhang; Laura Alder; Samuel Rosner; Aakash Desai; Alissa J. Cooper; Habte Yimer; Wiktoria Bogdanska; Abdul Rafeh Naqash; Ashtin Taylor; Utsav Joshi; Jennifer Carlisle; Stephane Champiat; Mehmet Altan; Maria Franco Vega; Josiah Halm; Joanna-Grace Manzano; Graeme Fenton; Yunan Nie; Kaiwen Wang; Mitchell Parma
errShare
errSave
From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development
err2025-09-17
err0
PREAI
errS. Champiat; K. Ouali; A. Laparra; A. Charalambous; M. Di Palma; K. Jordan; C. Massard; M. Aapro; F. Scotte
errShare
errSave
Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials
err2025-05-16
err0
PREAI
errAna Vaz Ferreira; Matthieu Delaye; Arnaud Pages; Antoine Hollebecque; Anas Gazzah; Rastio Bahleda; Jean-Marie Michot; Francois-Xavier Danlos; Lauren Seknazi; Vincent Goldschmidt; Clémence Hénon; Madonna Sakkal; Cristina Smolenschi; Stéphane Champiat; Aurelien Marabelle; Yohann Loriot; Céline Nagera Lazarovici; Zoé Ap-Thomas; Geoffroy Beraud Chaullet; Santiago Ponce Aix; Christophe Massard; Kaissa Ouali; Maxime Frelaut; Capucine Baldini
errShare
errSave
Artificial Intelligence for Drug Discovery: An Update and Future Prospects
err2025-02-01
err1
PREAI
errHarrison J. Howell; Jeremy P. McGale; Aurélie Choucair; Dorsa Shirini; Nicolas Aide; Michael A. Postow; Lucy Wang; Mickael Tordjman; Egesta Lopci; Augustin Lecler; Stéphane Champiat; Delphine L. Chen; Désirée Deandreis; Laurent Dercle
errShare
errSave
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer
errCANCER
IF5.1
err2025-01-28
err0
errOAAI
errSands, Jacob M.; Champiat, Stephane; Hummel, Horst-Dieter; Paulson, Kelly G.; Borghaei, Hossein; Alvarez, Jean Bustamante; Carbone, David P.; Carlisle, Jennifer W.; Choudhury, Noura J.; Clarke, Jeffrey M.; Gadgeel, Shirish M.; Izumi, Hiroki; Navarro, Alejandro; Lau, Sally C. M.; Lammers, Philip E.; Huang, Shuang; Hamidi, Ali; Mukherjee, Sujoy; Owonikoko, Taofeek K.
errShare
errSave
Is Local Ablative Stereotactic Radiation Therapy a Valuable Rescue Strategy for Time on Drug in Patients Enrolled in Phase I Trials?
err2024-12-01
err0
PREAI
errMavrikios, Antoine; Baldini, Capucine; Loriot, Yohann; Henon, Clemence; Marabelle, Aurelien; Postel-Vinay, Sophie; Champiat, Stephane; Danlos, Francois-Xavier; Quevrin, Clement; Lopes, Eloise; Gazzah, Anas; Bahleda, Rastislav; Massard, Christophe; Deutsch, Eric; Levy, Antonin
errShare
errSave
DETECTION OF CIRCULATING TUMOR DNA (CTDNA) IN CEREBROSPINAL FLUID (CSF) IN PATIENTS WITH GLIOBLASTOMA TREATED IN PHASE I CLINICAL TRIAL
err2024-11-11
err0
PREAI
errPorte, Marie; Beshiri, Kristi; Ouali, Kaissa; Postel-Vinay, Sophie; Massard, Christophe; Loriot, Yohann; Champiat, Stephane; Hollebecque, Antoine; Smolenschi, Cristina; Sakkal, Madona; Gazzah, Anas; Bahleda, Rastilav; Michot, Jean-Marie; Hueso, Thomas; Jeanson, Aurore; Rouleau, Etienne; Lacroix, Ludovic; Baldini, Capucine
errShare
errSave
Interim results of a phase I study of SGN-PDL1V (PF-08046054) in patients with PDL1-expressing solid tumors
err2024-09-01
err2
PREAI
errOliva, M.; Ochsenreither, S.; Le Tourneau, C.; Champiat, S.; Saleh, R.; Burkitt, K.; Nabell, L.; Steeghs, N.; Spreafico, A.; Minchom, A. R.; Patnaik, A.; Call, J. A.; Fontana, E.; Kotecki, N.; Garralda, E.; Zivi, A.; Riess, J. W.; Gupta, S.; Zhang, R.; Gillison, M.
errShare
errSave
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
err2024-07-01
err1
PREAI
errGeraud, Arthur; Hueso, Thomas; Laparra, Ariane; Bige, Naike; Ouali, Kaissa; Cauquil, Cecile; Stoclin, Annabelle; Danlos, Francois-Xavier; Hollebecque, Antoine; Ribrag, Vincent; Gazzah, Anas; Goldschmidt, Vincent; Baldini, Capucine; Suzzoni, Steve; Bahleda, Rastislav; Besse, Benjamin; Barlesi, Fabrice; Lambotte, Olivier; Massard, Christophe; Marabelle, Aurelien; Castilla-Llorente, Cristina; Champiat, Stephane; Michot, Jean-Marie
errShare
errSave
errShare
errSave
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations
err2024-06-01
err9
errOAAI
errRached, Layal; Laparra, Ariane; Sakkal, Madona; Danlos, Francois-Xavier; Barlesi, Fabrice; Carbonnel, Franck; De Martin, Eleonora; Ducreux, Michel; Even, Caroline; Le Pavec, Jerome; Michot, Jean-Marie; Ribeiro, Joana M.; Scotte, Florian; Aix, Santiago Ponce; Lambotte, Olivier; Baldini, Capucine; Champiat, Stephane
errShare
errSave
First-in-human phase I of anti-VISTA monoclonal antibody W0180 with and without anti-PD-1 pembrolizumab in patients with locally advanced or metastatic solid tumors
err2024-04-05
err2
PREAI
errGomez-Roca, Carlos; Champiat, Stephane; Cassier, Philippe; Jegou, David; Primard, Marie; Petain, Aurelie; Gueguen-Dorbes, Genevieve; Fabre, Claire; Melero, Ignacio; Marabelle, Aurelien
errShare
errSave